Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment
Sonire Therapeutics announced an $18 million Series A round led by Santé Ventures to advance its proprietary high‑intensity focused ultrasound (HIFU) system for pancreatic cancer. The device, which earned FDA Breakthrough Device designation in 2024, delivers non‑invasive thermal ablation in about 20 minutes without anesthesia. Sonire plans to use the capital to complete the SUNRISE‑I randomized trial in Japan, the first study pairing HIFU with chemotherapy for this lethal disease. The company is expanding from Tokyo to a new headquarters in Palo Alto.
Osteoboost Health Raises $8M for FDA-Cleared Bone Density Device
Osteoboost Health closed an $8 million financing round led by Ambit Health Ventures, with participation from several health‑focused investors. The company’s FDA‑cleared wearable belt delivers low‑magnitude vibration therapy to the lumbar spine and hips, slowing bone‑density loss by 85% in the...
The Clinical Resolution Gap: Why AI Can’t Fix Broken MSK Care Platforms
AI is reshaping musculoskeletal (MSK) care by automating documentation and triage, yet it largely fixes workflow rather than patient outcomes. Digital platforms tout engagement metrics—logins, exercise completion, chat usage—while employers care about episode duration, surgery avoidance, and total cost of...
HHS Launches $4M EMPOWER Prize Challenge to Enhance Living Kidney Donation
The U.S. Department of Health and Human Services has launched the 2026 KidneyX EMPOWER Prize Challenge, a $4 million competition to spur innovations that remove barriers to living kidney donation. Over 100,000 Americans await a kidney transplant, yet living donor numbers...
CMS Establishes New Billing Code for AI-Driven Calcium Analysis on CT Scans
The Centers for Medicare & Medicaid Services (CMS) announced a new national billing code under the Hospital Outpatient Prospective Payment System, effective April 1, 2026, for AI-driven analysis of coronary artery calcium (CAC) and aortic valve calcium (AVC) on chest CT scans....
Wavelet Medical Secures $7M to Scale AI Fetal Brain Monitoring Globally with Aegis Ventures
Wavelet Medical, a Yale‑spun AI startup, secured $7 million in seed funding and a co‑creation partnership with venture studio Aegis Ventures. The company has built the first non‑invasive fetal electroencephalography platform that uses abdominal sensors and proprietary AI to reconstruct real‑time...
Finding the Right Five Percent: How Machine Learning Is Reshaping Care Management
Machine learning is being woven into population health programs to move risk stratification from blunt, utilization‑based scores to disease‑centered, predictive analytics. By aggregating claims, labs and medication data into unified clinical profiles, ML models capture nonlinear patterns that linear regressions...
Ultralight Raises $9.3M to Launch AI-Native Operating System for Healthcare
Ultralight, formerly Vibrant Practice, secured $9.3 million led by The General Partnership to develop an AI‑native operating system tailored for Direct Primary Care. The platform aims to replace fragmented legacy EHRs with a unified, “invisible” infrastructure that reduces clinician charting time....
The AI Arms Race: Why PHTI Warns Healthcare ‘Bot Wars’ Are Inflating Medical Costs
The Peterson Health Technology Institute’s new report warns that artificial‑intelligence tools, while easing administrative tasks for individual health systems, are inflating system‑wide costs. AI‑driven prior‑authorization bots generate more submissions and denials, creating a “bot war” that adds $40‑$50 per request...
Symplr Appoints Former Edifecs Executive Venkat Kavarthapu as CEO
symplr, a leading enterprise healthcare operations software provider, announced Venkat Kavarthapu as its new chief executive officer, effective immediately. Kavarthapu, a 25‑year health‑tech veteran, previously served as CEO of Edifecs and guided its acquisition by Cotiviti in 2025. He replaces...
The Push for Side-by-Side Prescription Pricing in EHR Workflows
The article argues that prescribing decisions now hinge on real‑time cost information, urging EHR platforms to display side‑by‑side insurance and cash pricing. A recent Buzz Health survey shows 75% of prescribers view out‑of‑pocket costs as a major barrier, while 94%...
Death by a Thousand Vendors: Solera Report Reveals The Hidden Costs of Digital Health
Solera Health’s new report, based on a survey of 106 senior benefits leaders at firms with 1,000+ employees, reveals that 90% of large employers spend over $1 million annually on digital health solutions. The hidden operational expense of managing these fragmented...
The Perioperative AI Reality Check: Why Hospital Tech Fails Without Clinician Co-Design
Hospital leaders are rushing AI‑powered perioperative tools without clinician input, leading to low adoption and wasted spend. Andrew Fisher, MD, argues that the technology already exists, but success hinges on automating non‑clinical tasks, seamless workflow integration, and co‑design with anesthesiologists,...
EBSCO Clinical Decisions Report: 80% of Clinicians Trust Evidence-Based AI Tools
EBSCO Clinical Decisions released a report showing a stark trust gap in AI‑driven clinical decision support. While 89% of clinicians believe AI‑CDS will improve outcomes, 64% of patients would rather see a doctor who does not use AI. Evidence‑based AI...
Luminai Secures $38M, Inks Enterprise AI Partnership with Cleveland Clinic
Luminai announced a $38 million Series B round led by Peak XV Partners, lifting its total capital to $60 million. Simultaneously, the company unveiled an enterprise AI deployment with the Cleveland Clinic to automate the routing of faxed referrals. By embedding hospital‑specific standard operating procedures...
